From the College Athletics edition of October 1, 2026
Diagnostics narrative review: sports physicians should keep AI as a decision-support layer with human-in-the-loop return-to-play authority
UniCamillus and multi-institution coauthors / Diagnostics (MDPI) · Sports medicine clinical practice · International (Italy/US/France-centered author team; literature global)
- Publisher
- Diagnostics (MDPI)
- Original publication
- May 9, 2026
- Source retrieved
- 2026-10-02
What happened
Palermi et al. present a structured narrative review (PubMed/MEDLINE 2015–2024; about 1284 records screened to 74 included) arguing AI is reshaping sports-medicine decisions across injury risk, MSK imaging, rehab, return-to-play, and workflow, but should remain a probabilistic decision-support layer. They report injury-model AUCs commonly about 0.70–0.85 with limited external validity, warn that FDA 510(k) clearance is not athlete-specific outcome proof, and center the sports physician as human-in-the-loop integrator for high-stakes RTP. Conflicts disclosed include industry ties for some coauthors (e.g., Gleamer).
Why it matters
Not in archive; newly relevant with same-edition Huang SLR and Duan elite causal paper as clinical-governance counterweight for collegiate sports-medicine AI purchasing after recent injury-model archive themes.
Evidence and measured results
Full article opened via HTTPS WebFetch (direct curl received 403). Abstract/conclusions state decision-support framing and human-in-the-loop role; methods describe narrative synthesis of 74 studies; sections detail imaging devices table and competency framework. Collegiate-specific trials are not the focus; transfer requires local governance.
Limitations and uncertainty
Narrative not systematic meta-analysis; search ended Dec 2024; some authors have AI-imaging industry roles; not NCAA-regulation guidance.
Put this evidence to work
Lighthouse Advisory interpretation, grounded in this source. Enriched 2026-10-02; this does not change the original publication date. Each role follows the same checklist so takeaways compare across sources.
Sales
Role takeaway
- Customer problem
- Sports medicine groups face AI vendor pressure without a clear rule that physicians retain high-stakes decisions.
- Stakeholders
- Head team physician
- Athletic trainer leadership
- AD
- University counsel/privacy
- Discovery questions
- Which decisions will AI inform versus decide?
- How are overrides logged?
- What athlete groups are in the training data?
- Value hypothesis
- Clinician-centered AI support may improve information synthesis if RTP and selection authority stay human—and if validation matches the use case.
- Potential engagement
- Policy + pilot design for one AI imaging or load-summary tool under sports-medicine governance.
- Unsupported claims
- AI replaces team physician RTP judgment
- 510(k) clearance proves athlete outcome benefit
- Uniform performance across all athlete populations
Pre-sales engineering
Role takeaway
- Fit
- Decision-support CDSS/imaging/rehab analytics with mandatory human confirmation.
- Architecture and integration
- Read-only model outputs into clinical workflow; override capture; no automated clearance state changes.
- Prerequisites
- Intended-use alignment
- EHR/PACS connectors
- Uncertainty UX
- Access control
- Constraints
- Limited athlete-specific validation
- Automation bias
- LLM hallucination risk
- Security
- Protect multimodal health data; ban secondary commercial use; breach notification to athletes where required.
- Proof of value
- Override/edit rates
- Time-to-relevant-context
- Disagreement cases reviewed weekly
Delivery
Role takeaway
- Work
- Write AI-in-clinic SOP, train physicians/ATCs, pilot one workflow, and audit overrides before expansion.
- Dependencies
- Vendor clinical validation dossier
- Counsel/privacy
- Change management time
- Ownership
- Head team physician owns clinical decisions; athletics IT owns integrations.
- Skills and adoption
- Build AI literacy, uncertainty communication, and bias checks into medical staff training.
- Governance checkpoints
- Pre-go-live ethics/privacy review
- 30-day override audit
- Equity performance check
- Acceptance criteria
- 100% high-stakes decisions documented as physician-final
- No autonomous RTP flag in production
- Risks
- Automation bias
- Vendor conflict influence
- Widening care gaps if only elite sports funded
Implementation considerations
Lighthouse Advisory interpretation across the operating dimensions a public-sector buyer must settle before this evidence becomes a design. Each note answers the question under its heading for this specific source.
Architecture and integration
What must connect, and where does the AI sit in the workflow?
Favor architectures that surface uncertainty, preserve clinician override, and integrate multimodal inputs into EHR/team workflows without autonomous RTP clearance.
Governance
Who approves, reviews and stays accountable for outcomes?
Codify that AI outputs cannot alone clear RTP or determine scholarships/playing time; require bias monitoring for underrepresented athlete groups.
Security and privacy
What data, permissions and controls need testing?
Continuous wearable/imaging/EHR fusion heightens ownership, secondary use, and commercialization risks the authors flag—contracts must follow.
Accessibility and workforce
Who is affected, and what skills or accommodations follow?
Framework demands new clinician AI-appraisal skills; under-resourced sports may lack training time, widening tool disparities.
Procurement
What should contracts, pricing and exit terms secure?
Purchase only tools with clear intended use, override design, and athlete-population validation—not marketing accuracy alone.
Operating model
Which teams own the service once it runs?
Reinforces physician-final operating model for AI-augmented sports medicine in collegiate programs.
Publication history
- 2026-10-01College Athletics · Issue 255 resources
Stable resource ID: palermi-diagnostics-ai-sports-medicine-framework-2026-05-09